workspace_premiumPRO EDITION Pro subscriber access

ADHD Evidence Weekly Brief

2026-04-08 · Adult ADHD: underdiagnosis, compensation, functional impairment

This PRO brief links adult ADHD underdiagnosis with compensation, reads functional impairment and burnout as context (not a diagnostic tool), and shows how to read pharmacotherapy as a Rapid Review. For pre-visit context only.
01

Why diagnosis is delayed — underdiagnosis and compensation

Adult ADHD PMID 36743427 Review · 2023

In adulthood, symptoms may be hidden by compensation rather than “absent.” Gaps between DSM-5 framing and clinic realities can add detection delay.

💡 PRO insight

Shift from a pure “willpower” frame toward underdiagnosis as a possibility. Information only—not a diagnostic verdict.

PubMed: 36743427

02

Where functional impairment appears

Impairment review J Attn Disord DOI 10.1177/10870547231158572

Adult ADHD can affect work, relationships, and daily routines; strain may stack across domains.

🎯 Practice note

Beyond symptom checklists, note which life areas repeatedly fail—this grounds clinical conversation.

DOI: 10.1177/10870547231158572

03

Burnout cycle — explanatory frame (not a test)

Explanatory frame Not diagnostic

Note: This is not a clinical instrument—only a way to organise functional context before visits.

  • Step 1: Heavy advance control to prevent mistakes/omissions
  • Step 2: Short-term performance holds while cognitive cost rises
  • Step 3: Slow recovery, executive strain, emotional depletion
  • Step 4: Repeated “held it together, then collapsed” cycles

04

Impairment-based care frame + card 04 (E-1) caution

Draft frame E-1 pending

Pair symptom questions with impairment questions; start with 1–2 priority domains (work, relationships, routines). Combine medication and non-medication strategies with risk, comorbidity, and misuse context.

⚠️ E-1 citation pending

Card 04 (2025 axis candidate): DOI/PMID not final—no strong numeric claims; not a sole primary source for core claims.


05

Medication safeguards (Rapid Review) + E-5 supplementary source

Rapid Review Not guideline NBK610422

Source #6 is a Rapid Review/summary. Head-to-head evidence is thin in places; misuse/diversion risk may favour non-stimulant contexts. Not an absolute guideline benchmark.

⚠️ E-5 preliminary review

Card 05: identifiers pending—supplementary only; avoid numeric over-read.

NCBI Bookshelf NBK610422
💬

Sample questions for clinicians (draft)

  1. Which impairment domain should we prioritise first in my pattern?
  2. How do you assess symptoms masked by compensation?
  3. What risk factors guide medication vs non-medication choices for me?
  4. What should we track at 4–8 weeks after assessment?
  5. How should I monitor worsening burnout signals?
📖

Sources this batch

Card Source ID
001 Adult ADHD review (2023) PMID: 36743427
002 J Attn Disord · impairment DOI: 10.1177/10870547231158572
003 CADTH Rapid Review (Bookshelf) NBK610422 · Rapid Review (not guideline)
004 2025 axis candidate DOI/PMID pending (E-1)
005 Supplementary review DOI/PMID pending (E-5)
🛑 Batch caveats and limits
  • 📋 Rapid Review: Card 003 and the medication section are not absolute guidelines.
  • ⚠️ E-1/E-5: Identifiers pending—auxiliary/preliminary use only; no strong numeric claims.
  • 📋 Burnout cycle: Explanatory frame, not a diagnostic instrument.
  • 🎯 No self-diagnosis push: Observation notes support visits, not screening tools.
Disclaimer — Not medical advice; does not provide diagnosis, prescription, or dosing instructions. All decisions belong with a qualified clinician.